Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | RAB9A | P51151 | 9/20 | 0.60 |
| ▸ | NPC1 | O15118 | 7/20 | 0.60 |
| ▸ | MAPT | P10636 | 6/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.60 |
| ▸ | MMP2 | P08253 | 2/20 | 0.57 |
| ▸ | MMP9 | P14780 | 2/20 | 0.57 |
| ▸ | MMP8 | P22894 | 2/20 | 0.57 |
| ▸ | MMP13 | P45452 | 2/20 | 0.57 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2062399 | 0.87 | MAPT (0.60) | ALDH1A1MEN1KMT2ARAB9ANPC1 | |
| SCHEMBL13054081 | 0.83 | RAB9A (0.56) | ALDH1A1MEN1KMT2ARAB9ANPC1 | |
| SCHEMBL1191852 | 0.82 | RAB9A (0.50) | ALDH1A1MEN1KMT2ARAB9ANPC1 | |
| SCHEMBL2420144 | 0.81 | RAB9A (0.61) | ALDH1A1MEN1KMT2ARAB9ANPC1 | |
| SCHEMBL15172875 | 0.81 | RAB9A (0.61) | ALDH1A1MEN1KMT2ARAB9ANPC1 | |
| SCHEMBL11443651 | 0.81 | MEN1 (0.62) | ALDH1A1MEN1KMT2ARAB9ANPC1 | |
| SCHEMBL29362134 | 0.81 | RAB9A (0.61) | ALDH1A1MEN1KMT2ARAB9ANPC1 | |
| SCHEMBL10173106 | 0.80 | RAB9A (0.65) | ALDH1A1MEN1KMT2ARAB9ANPC1 | |
| SCHEMBL2244450 | 0.80 | RAB9A (0.60) | ALDH1A1MEN1KMT2ARAB9ANPC1 | |
| SCHEMBL10173135 | 0.80 | RAB9A (0.60) | ALDH1A1MEN1KMT2ARAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12227524-B2 | Anti-infective compounds | INSTITUT PASTEUR KOREA (KR) | 2025-02-18 | — | — | US | disclosed |
| US-20220153756-A1 | ANTI-INFECTIVE COMPOUNDS | INSTITUT PASTEUR KOREA (KR) | 2022-05-19 | — | — | US | disclosed |
| US-20220153756-A1 | ANTI-INFECTIVE COMPOUNDS | INSTITUT PASTEUR KOREA (KR) | 2022-05-19 | — | — | US | disclosed |
| US-11279714-B2 | Anti-infective compounds | INSTITUT PASTEUR KOREA (KR) | 2022-03-22 | — | — | US | disclosed |
| CN-107027307-B | Anti-infective compounds | 韩国巴斯德研究所 | 2020-12-22 | — | — | CN | disclosed |
| EP-3157904-B1 | ANTI-INFECTIVE COMPOUNDS | PASTEUR INSTITUT KOREA (KR) | 2020-11-18 | — | — | EP | disclosed |
| EP-3157904-B1 | ANTI-INFECTIVE COMPOUNDS | PASTEUR INSTITUT KOREA (KR) | 2020-11-18 | — | — | EP | disclosed |
| EP-2589592-B1 | NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF | FUJIFILM CORP (JP) | 2018-08-22 | — | — | EP | disclosed |
| EP-2684874-B1 | Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and C-met inhibitors | CEPHALON INC (US) | 2017-05-17 | — | — | EP | disclosed |
| US-20170121349-A1 | Anti-Infective Compounds | INSTITUT PASTEUR KOREA (KR) | 2017-05-04 | — | — | US | disclosed |
| US-20070255057-A1 | Mono-nitration of aromatic compounds via nitrate salts | CEDILOTE MIALL | 2007-11-01 | — | — | US | disclosed |
| US-20070255057-A1 | Mono-nitration of aromatic compounds via nitrate salts | CEDILOTE MIALL | 2007-11-01 | — | — | US | disclosed |
| EP-1847532-A1 | IGF-1R INHIBITOR | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2007-10-24 | — | — | EP | disclosed |
| US-20060223868-A1 | Heterocyclic amides exhibiting and inhibitory activity at the vanilloid receptor 1(vr1) | ASTRAZENECA AB (SE) | 2006-10-05 | — | — | US | disclosed |
| EP-1622884-A1 | NEW HETEROCYCLIC AMIDES EXHIBITING AN INHIBITORY ACTIVITY AT THE VANILLOID RECEPTOR 1 (VR1). | AstraZeneca AB (SE) | 2006-02-08 | — | — | EP | disclosed |
| WO-2004096784-A1 | NEW HETEROCYCLIC AMIDES EXHIBITING AN INHIBITORY ACTIVITY AT THE VANILLOID RECEPTOR 1 (VR1). | ASTRAZENECA AB (SE) | 2004-11-11 | — | — | WO | disclosed |
| EP-0561475-B1 | Bleachable polymeric filter dyes | EASTMAN KODAK CO (US) | 2000-03-01 | — | — | EP | disclosed |
| EP-0561475-A1 | Bleachable polymeric filter dyes | EASTMAN KODAK COMPANY (US) | 1993-09-22 | — | — | EP | disclosed |
| US-5244994-A | Benzoxazole styryl chromophore attached to polymer, X-ray films, high speed | EASTMAN KODAK COMPANY (US) | 1993-09-14 | — | — | US | disclosed |
| EP-0029720-A1 | The development of lithographic films | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1981-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060223868-A1 | Heterocyclic amides exhibiting and inhibitory activity at the vanilloid receptor 1(vr1) | AVPR1A, AVPR2, TRPV1 | ALDH1A1 726/4885MEN1 2859/4885KMT2A 3280/4885 |
| US-20220153756-A1 | ANTI-INFECTIVE COMPOUNDS | RABGGTB, ELANE, SERPINB1 | ALDH1A1 3932/4885MEN1 3685/4885KMT2A 4781/4885 |
| US-12227524-B2 | Anti-infective compounds | RABGGTB, ELANE, SERPINB1 | ALDH1A1 3932/4885MEN1 3685/4885KMT2A 4781/4885 |
| US-11279714-B2 | Anti-infective compounds | FNTB, LSS, PGLS | ALDH1A1 1595/4885MEN1 3545/4885KMT2A 4578/4885 |
| US-20070255057-A1 | Mono-nitration of aromatic compounds via nitrate salts | NOS2, NOS3, NOS1 | ALDH1A1 722/4885MEN1 2021/4885KMT2A 2556/4885 |
| US-20170121349-A1 | Anti-Infective Compounds | FNTB, LSS, PGLS | ALDH1A1 1595/4885MEN1 3545/4885KMT2A 4578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.